With its unmatched accuracy and insight, the Metabolic Screen (HHD) ushers in a new era of diagnostic precision by providing a thorough assessment of metabolic health. Designed using state-of-the-art technology and novel approaches, this screening panel offers a detailed evaluation of metabolic parameters, highlighting possible anomalies or dysfunctions with remarkable accuracy.

Fundamentally, the Metabolic Screen (HHD) combines a wide range of distinct biomarkers and molecular targets, allowing medical professionals to explore the complexities of metabolic physiology in great detail. This panel provides a comprehensive picture of metabolic health, enabling early identification and management in cases of metabolic diseases or dysregulation. It includes markers of insulin resistance, metabolic syndrome, glucose, and lipid profiles.

Furthermore, the Metabolic Screen (HHD) goes beyond conventional diagnostic limitations by combining cutting-edge data analytics and